Clinical Trial Update: A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and tolerability of a sitagliptin/simvastatin fixed-dose combination in adults with type 2 diabetes inadequately controlled …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• Sitagliptin (sitagliptin)
• Sitagliptin/Simvastatin Fixed-Dose Combination

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-05-30